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BACKGROUND: Dietary (n-6)-polyunsaturated fatty acids influence cancer development, but the mechanisms have not been well
characterised in gastric carcinoma.
METHODS: We used two in vivo models to investigate the effects of these common dietary components on tumour metastasis. In a
model of experimental metastasis, immunocompromised mice were fed diets containing linoleic acid (LA) at 2% (LLA), 8% (HLA) or
12% (VHLA) by weight and inoculated intraperitoneally (i.p.) with human gastric carcinoma cells (OCUM-2MD3). To model
spontaneous metastasis, OCUM-2MD3 tumours were grafted onto the stomach walls of mice fed with the different diets. In in vitro
assays, we investigated invasion and ERK phosphorylation of OCUM-2MD3 cells in the presence or absence of LA. Finally, we tested
whether a cyclooxygenase (COX) inhibitor, indomethacin, could block peritoneal metastasis in vivo.
RESULTS: Both the HLA and VHLA groups showed increased incidence of tumour nodules (LA: 53%; HLA: 89%; VHLA: 100%;
Po0.03); the VHLA group also displayed increased numbers of tumour nodules and higher total volume relative to LLA group in
experimental metastasis model. Both liver invasion (78%) and metastasis to the peritoneal cavity (67%) were more frequent in VHLA
group compared with the LLA group (22% and 11%, respectively; Po0.03) in spontaneous metastasis model. We also found that the
invasive ability of these cells is greatly enhanced when exposed to LA in vitro. Linoleic acid also increased invasion of other scirrhous
gastric carcinoma cells, OCUM-12, NUGC3 and MKN-45. Linoleic acid effect on OCUM-2MD3 cells seems to be dependent on
phosphorylation of ERK. The data suggest that invasion and phosphorylation of ERK were dependent on COX. Indomethacin
decreased the number of tumours and total tumour volume in both LLA and VHLA groups. Finally, COX-1, which is known to be an
important enzyme in the generation of bioactive metabolites from dietary fatty acids, appears to be responsible for the increased
metastatic behaviour of OCUM-2MD3 cells in the mouse model.
CONCLUSION: Dietary LA stimulates invasion and peritoneal metastasis of gastric carcinoma cells through COX-catalysed metabolism
and activation of ERK, steps that compose pathway potentially amenable to therapeutic intervention.
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Dietary variables, including dietary fats, total energy and micro-
nutrients clearly influence carcinogenesis in animal models, (for
review, see Sauer et al, 2007). Epidemiological evidence suggests
that in some cases, these findings are relevant to human cancers
(Michels et al, 2007). Dietary variables may explain the changing
frequency of cancer seen in immigrants, who acquire the dietary
habits of their adopted country (Armstrong and Doll, 1975).
However, controlled prospective studies have not always demon-
strated major effects of dietary fat on cancer risk (for example, see
Prentice et al, 2007). Experimental evidence relating dietary fat and
tumour development has been obtained from animal models for a
variety of cancers (De Vries and van Noorden, 1992; Connolly et al,
1996; Fischer et al, 1996; Rose, 1997b; Rose and Connolly, 1998),
including some gastric carcinomas (Silva et al, 1995; Lopez-
Carrillo et al, 1999). Specifically, (n-6)-polyunsaturated fatty acids
(PUFAs) have been shown to promote carcinogenesis (Braden and
Carroll, 1986) and stimulate metastatic behaviour of tumour cells
(Hubbard and Erickson, 1987; Rose, 1997b). Linoleic acid (LA),
an important (n-6)-PUFA, is metabolised in a variety of ways,
including conversion to arachidonic acid (AA) (Lichtenstein et al,
1998), a precursor of a variety of highly active eicosanoids formed
through cyclooxygenase (COX)- and lipoxygenase (LOX)-mediated
reactions (Zha et al, 2004; Furstenberger et al, 2006). The COX-1 is
constitutively expressed in most tissues, generating basal levels of
prostaglandins, whereas COX-2 is generally expressed at lower
levels and can be induced by a variety of extracellular stimuli
(Kujubu et al, 1991). One epidemiological study showed that
the risk of developing stomach cancers was reduced in patients
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staking a COX inhibitor (Farrow et al, 1998), and metastasis was
suppressed by non-steroidal anti-inflammatory drugs, inhibitors
of these key enzymes (Vanderhoek et al, 1984).
Gastric carcinoma is one of the most frequent and lethal
malignancies in the world (Parkin et al, 1999). Aggressive
scirrhous gastric carcinoma, a diffusely infiltrating adenocarcino-
ma, is characterised by rapid progression, invasion and frequent
dissemination into the abdominal cavity, leading to peritoneal
metastasis (Sowa et al, 1989). The choice of treatment depends on
knowledge of the natural history of the disease and mechanisms of
spread. Because such information is generally lacking, various
treatment regimens have been disappointing and advanced gastric
carcinoma remains incurable, with a median survival of 6–10
months (Park et al, 2004). We have previously shown that PUFAs
promote the metastasis of breast carcinoma cells by a mechanism
involving stimulation of adhesion to collagen type IV and activa-
tion of PKC and p38 MAPK pathways (Palmantier et al, 1996;
Paine et al, 2000). Whether fatty acids promote the metastasis of
gastric carcinoma in a mouse model is the focus of this report.
MATERIALS AND METHODS
Cell lines and cell culture
A highly metastatic human gastric carcinoma cell line, OCUM-
2MD3, was established from a parental human cell line, OCUM-
2M, using orthotopic tissue implantation in nude mice (Nishimura
et al, 1996; Yashiro et al, 1996; Matsuoka et al, 1998). Another
gastric carcinoma cell line, OCUM-12, was also provided by
Dr Kosei Hirakawa, Osaka City University, Osaka, Japan. NUGC3
and MKN-45 were obtained from JCRB cell bank (Osaka, Japan).
Cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM, Life Technologies, Grand Island, NY, USA), supplemen-
ted with 10% heat-inactivated fetal bovine serum (HyClone, Logan,
UT, USA) (complete DMEM), at 371C in a humidified atmosphere
containing 5% CO2.
Antibodies and reagents
Linoleic acid, LA, AA and nordihydroguaiaretic acid were from
Cayman Chemical Co., Ann Arbor, MI, USA. Protease inhibitors
were from Sigma-Aldrich, St Louis, MO, USA or Chemicon,
Billerica, MA, USA. International Sources of primary antibodies
were as follows: ERK1/2 and phospho-ERK1/2, Upstate Biotech-
nology, Lake Placid, NY, USA; phospho-JNK, New England
Biolabs, Ipswich, MA, USA; actin, Santa Cruz Biotechnology,
Santa Cruz, CA, USA; phospho-p38, Promega, Madison, WI, USA;
COX-1, Cayman; COX-2, Oxford Biomedical, Oxford, MI, USA; and
GAPDH, Chemicon International. The COX-1 and COX-2 stan-
dards for gel electrophoresis were partially purified preparations
from Cayman.
Animals and diets
Female athymic nude mice (NCr-nu/nu; 4-week-old) were from
Charles River Laboratories Portage, MI, USA and were maintained
in micro-isolator cages in a pathogen-free facility. All studies were
conducted in accordance with the NIH Guide for the Care and Use
of Laboratory Animals, and all experiments were approved by the
NIEHS Institutional Animal Care and Use Committee. Mice were
divided into three groups of 19 mice each for the experimental
metastasis study (injection of tumour cells into the intraperitoneal
(i.p.) space), and two groups of 10 mice each for the spontaneous
metastasis study (tumour fragments sutured onto the stomach
wall). The mean weight per mouse in each group was the same.
Diets were based on the purified AIN-76A diet (Rose et al, 1993)
and prepared by BioServe Inc., Frenchtown, NJ, USA. The diets
were isocaloric (4.45kcalg
 1) and contained the same high-fat
content (23%, w/w), supplemented with LA-rich safflower oil and
saturated fatty acid-containing coconut oil in different ratios to
yield 2% (LLA), 8% (HLA) or 12% (VHLA) (w/w) LA (Supple-
mentary Tables 1 and 2) (Hubbard and Erickson, 1987). Diets were
sterilised by irradiation with
60Co and stored at 41C in heat-sealed
plastic bags flushed with nitrogen. Feeding of the experimental
diets commenced 7 days before injection or transplantation of the
tumour cells.
In vivo metastasis models
Cells were harvested from subconfluent cultures, collected by
centrifugation, washed once and resuspended in serum-free
DMEM at 1 10
7 cells per ml. For experimental metastasis, mice
were injected i.p. with 2 10
6 cells in 200ml, maintained on
experimental diets for an additional 4 weeks and then killed using
CO2. The maximum (L) and perpendicular (W) diameters of
metastatic nodules at necropsy were measured with a vernier
caliper and the volume of nodules was calculated as follows:
4=3pL2W
For spontaneous metastasis studies, tumour fragments for
implantation were prepared by injecting nude mice subcuta-
neously with 5 10
6 OCUM-2MD3 cells. At 4 weeks after
inoculation, subcutaneous tumours were excised and cut into
3-mm square pieces. Additional nude mice, maintained on the
appropriate diet, were anaesthetised and an incision made through
the median upper abdominal line and peritoneum. The stomach
was exposed, and a single tumour fragment was sutured onto the
middle of the greater curve of the glandular stomach. At 4 weeks
after implantation, mice were killed and the stomach and any
metastatic colonies were removed. Visible tumours were counted,
measured, fixed in 10% formalin, embedded in paraffin and cut
into 2-mm-thick slices for histological examination.
Indomethacin (Sigma-Aldrich) was dissolved in absolute
ethanol, diluted as required to provide 10mg indomethacin per l
(0.2% ethanol) in the drinking water (Lala et al, 1997) and
administered starting 7 days before injection of tumour cells and
throughout the study. Control mice received ethanol (0.2%) in
the drinking water. Systemic toxicity was not evident in any
of these mice.
Cell growth assays
The OCUM-2MD3 cells were plated at a density of 1 10
4 cells per
well in 96-well plates. Cells were washed with phosphate-buffered
saline (PBS), incubated with or without LA (3, 30 or 60mM) for 72h
and then treated with 5mgml
 1 MTT (3-(4,5-dimethyl-2-thiazyl)-
2,5-diphenyl-2H-tetrazolium bromide) (Sigma-Aldrich) for 4h at
371C. The relative active number of cells was measured as
absorbance at 570nm using a microtiter plate reader (PM2004;
Wako, Osaka, Japan).
Flow cytometry
Apoptosis was detected using flow cytometry by staining cells
with annexin V-FITC and propidium iodide (BD Pharmingen, San
Diego, CA, USA) labelling. The OCUM-2MD3 cells treated with
vehicle (ethanol) and 30mmoll
 1 of LA for 30min were seeded at a
density of 1.0 10
5 cells per ml in 100-mm plates. Cells were
stained with annexin V-FITC and propidium iodide and analysed
by flow cytometry using FACScan.
Invasion assay
Tumour cell invasion was assayed as described previously with
some modifications (Albini et al, 1987). Briefly, Transwell cell
culture chambers (Millipore Co., Billerica, MA, USA), equipped
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swith a microporous membrane filter (pore size: 12mm), were coated
with Matrigel (10mg per filter) (Becton Dickinson, Bedford, MA,
USA). The OCUM-2MD3 cells, and the other scirrhous gastric
carcinoma cell lines, OCUM-12, NUGC3 and MKIN-45, were
resuspended to 5 10
5 cells per ml in complete DMEM containing
either 30mmoll
 1 LA or the appropriate amount of vehicle (ethanol),
added to the upper compartment of the chamber and incubated at
371Ci n5 %C O 2. We choose the LA concentration from previously
published data, such as Rose et al (1994). Similarly, the effect of
30mmoll
 1 AA, a metabolite of LA, on the invasion of OCUM-2MD3
cells was investigated. When relevant, cells were treated with the ERK
inhibitor, PD98059 (Calbiochem, La Jolla, CA, USA), or p38 inhibitor,
SB203580, for 1h, or with the COX inhibitor, indomethacin, or LOX
inhibitor, NDGA, for 30min; control cells received vehicle only.
Invasion was assessed by counting cells that appeared on the
underside of the membrane, counting three fields (magnification,
 200) per well and three wells per experimental group.
Preparation of cell lysates for western blotting
Subconfluent cells were washed with serum-free medium, resus-
pended at 5 10
5 cells per ml and allowed to recover in 5% CO2 at
371C for 20min. Specific ERK and p38 inhibitors, PD98059 and
SB203580 (Calbiochem), respectively, or indomethacin, were
dissolved in DMSO and added to cells 1h (PD98059 and
SB203580) or 30min (indomethacin) before treatment with
30mmoll
 1 of LA for the indicated time period. Cells were
collected by centrifugation and resuspended in RIPA buffer
(50mmoll
 1 Tris-HCl (pH 7.5), 30mmoll
 1 Nonidet P-40,
150mmoll
 1 NaCl, 200IUl
 1 aprotinin, 1mgl
 1 leupeptin,
0.5mmoll
 1 sodium orthovanadate, 50mmoll
 1 sodium fluoride,
2mmoll
 1 EDTA, 1% Triton X-100, 1% sodium deoxycholate and
0.1% SDS). Cell lysates were then passed through a 23-G needle
and clarified by centrifugation. Protein concentrations were
determined using the BCA protein assay (Pierce, Rockford, IL,
USA). With mouse tissue samples, 100–500mg of each sample was
crushed with a mortar and pestle in a liquid nitrogen bath. After
the addition of five volumes of ice-cold 50mmoll
 1 Tris-HCL (pH
7.4), 1mmoll
 1 EDTA, samples were homogenised, centrifuged
and supernatants used for immunoblot analysis.
Immunoblots
Whole cell lysates were resolved by 10% SDS-PAGE and transferred
to PVDF membranes (Millipore Co.) in Tris-glycine buffer contain-
ing 10% methanol. Membranes were blocked with 5% skim milk or
3% BSA (fraction V, MP Biomedicals, Solon, OH, USA) in Tris-
buffered saline with 0.1% Tween 20 (TBST), incubated with primary
antibodies at room temperature for 1h or at 41C overnight, followed
by the appropriate secondary antibody at room temperature for
45min. After incubations with primary and secondary antibody,
blots were washed with TBST and visualised using either Supersignal
chemiluminescent substrate (Pierce) or Amersham ECL detection
system, Piscataway, NJ, USA.
Immunohistochemical detection of the COXs
The streptavidin–biotin peroxidase complex method was used for
immunohistochemistry. Slides of tissue samples were treated with
0.3% hydrogen peroxide in methanol for 45min. Antibodies to
COX-1 and COX-2 were applied to sections at a dilution of 5 and
10mgl
 1, respectively, with an overnight incubation at 41C.
Sections from previously studied cases of colorectal cancer known
to express COX-2 were used as positive controls. Antibody binding
was detected using a Vecta Stain Elite kit (Vector Laboratories,
Burlingame, CA, USA) and counterstained with haematoxylin.
RT-PCR detection of COX-1 mRNA
Quantitative reverse transcription (RT)-PCR was used to deter-
mine relative expression levels of COX-1 mRNA. Total RNA from
tissues was isolated using the RNeasy Midi Kit (Qiagen, Valencia,
CA, USA). A measure of 1mg of total RNA from each tissue was
reverse transcribed by Superscript II (Invitrogen, Carlsbad, CA,
USA). Primers chosen for the cloned 300-bp PCR fragment were:
sense 50-TGCCCAGCTCCTGGCCCGCCGCTT-30; antisense 50-G
TGCATCAACACAGGCGCCTCTTC-30. The PCR reactions were
denatured for 4min at 941C, followed by 40 cycles at 941C for
1min, 631C for 1min and 721C for 1min. For b-actin amplification
(sense primer 50-CGGGGACCTGACTGACTACC-30;a n t i s e n s e
primer 50-AGGAAGGCTGGAAGAGTGC-30), reactions involved
denaturation at 941C for 1min, annealing at 571C for 1min and
extension at 721C for 1min. The PCR products were separated on
2% agarose gels and visualised using ethidium bromide.
Fatty acid profiling by mass spectrometry
Duodenal tissues for extraction were excised, rinsed thoroughly in
PBS three times and weighed (mass ranged from 29 to 57mg).
Sufficient water was added to each sample to bring the total mass
of water and tissue to 60mg. For blood plasma extractions, a 25ml
volume of separated plasma was used. Subsequent volumes were
reduced by 5/12 to maintain solvent ratios. All samples received
2.5ml of butylated hydroxytoluene (as an antioxidant) in methanol
at a concentration of 10gl
 1. Lipids were then extracted from
duodenal tissue and blood plasma by the Folch procedure (Folch
et al, 1957) and 0.5ml of each sample was loaded onto the column.
Fatty acid methyl ester peaks were identified by comparing spectra
with those in the NIST mass spectral library, and by comparing
them with spectra and retention times of Supelco 37 Component
FAME Mix (Sigma-Aldrich). Relative abundances were determined
from the total ion chromatogram. A correction factor was applied
to convert peak areas to weight percentages on the basis of the
results obtained from analysis of the Supelco FAME mix. Mean
weight percentages and standard deviations were calculated for
four biological replicate samples from each diet group.
Statistical analysis
Analysis of incidence was conducted using Fisher’s exact tests.
Incidence data represented in Table 1 were analysed by two-sided
Fisher’s exact test, as the effect of LA on tumour formation in this
experiment was unknown. Incidence data represented in Tables 2
Table 1 Effect of dietary fatty acid intake on incidence of grossly visible
peritoneal metastatic nodules from OCUM-2MD3 human gastric carcinoma
cells in nude mice
Dietary group
Metastasis LLA HLA VHLA
Incidence 10/19 (53%)
a 17/19 (89%)
a,b 19/19 (100%)
a,b
Total no. 28 43 79
o1mm 1 2 6
1–3mm 17 18 36
43mm 10 23 37
Nodules per mouse 1.5±2.0
c 2.3±1.8
c 4.2±2.7
b,c,d
Total tumour volume
Per mouse (mm
3) 409±241
c 657±991
c 6674±9213
b,c,d
Body weight 16.2±0.8
c 17.1±1.2
c 17.1±0.7
c
Abbreviations: HLA¼high linoleic acid; LLA¼low linoleic acid; VHLA¼very high
linoleic acid.
aValues are means±s.e.m.
bSignificantly different from LLA group;
Po0.03.
cValues are means±s.e.m.
dSignificantly different from HLA group; Po0.03.
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sand 3 were analysed by one-sided Fisher’s exact tests based on
experimental data from Table 1, which suggested an increase in
tumour formation as a function of LA. All data are reported as
mean±standard error of the means.
In the analysis of fatty acids present in duodenal tissue and
plasma (Supplementary Table 3 and 4, respectively), residuals were
examined to verify the shape of the distribution as normal, given
the small sample size used in this analysis. On the basis of these
results, parametric analysis was used to determine the significance
of observed changes in fatty acids as a function of dietary LA. Data
are reported as mean±standard deviation (s.d.).
To determine whether indomethacin had a significant effect on
number of tumour nodules per animal and the total tumour
volume per animal in combination with a low- or high-LA diet
in vivo (Table 3), two-way analysis of variance (ANOVA) for
independent samples was utilised. Data are reported as mean±s.d.
In vitro data comparing treated and control groups and in vivo
data comparing number of nodules and total tumour volume per
animal were analysed using the Student’s t-test. Data are reported
as means±s.d. In all cases, P-values of o0.05 were considered
statistically significant.
RESULTS
LA stimulates metastasis of a human gastric cancer
cell line
To determine whether LA would stimulate metastasis of gastric
carcinoma cells, OCUM-2MD3 human gastric carcinoma cells were
injected into the peritoneal cavities of Balb/c nude mice, which
were fed high-fat diets containing 2% (LLA), 8% (HLA) or 12%
(VHLA) LA. Mean per mouse body weights did not differ between
the three dietary groups at either the beginning or the end of the
study (Table 1). Both the HLA and VHLA groups showed a higher
incidence of metastasis compared with the LLA group (Table 1),
despite identical total fat and energy intakes (Supplementary Table 1).
Interestingly, the mean number of metastatic nodules per mouse
and the mean total tumour volumes in the VHLA group increased
over those in either the LLA or HLA groups (Table 1 and
Figure 1B). Metastatic colonies, identified as white nodules in the
peritoneal cavity (Figure 1A, right panel), were primarily located at
the omentum and occasionally at the lesser curvature of stomach,
mesentery and parietal peritoneum. Tumour location did not vary
between dietary groups.
We next used orthotopic implantation of tumours on the
stomach wall to examine the effects of dietary LA on OCUM-2MD3
tumour growth and spontaneous peritoneal metastases. Because
the VHLA group showed the largest effect in the earlier model, and
to reduce the number of mice used in this model, in which donor
and recipient mice are required, we chose to test for an effect on
spontaneous metastasis in mice fed only the LLA and VHLA diets.
All the mice receiving tumour cell transplants developed detectable
tumours on the stomach wall (Figure 1A, middle panel). The mean
volume of the original engrafted tumours in the VHLA group was
not different from that of the LLA group (P¼0.0854) (Table 2),
suggesting that there were no effects of the diet on growth of the
original tumour cells. Metastatic colonies, identified by histological
examination, appeared both in the peritoneal cavity and in lymph
nodes, but not in the lungs.
Metastasis to the peritoneum and liver invasion were signifi-
cantly increased in the VHLA group (Table 2), whereas lymph
node metastasis (Figure 1A, left panel) did not increase when
compared with the LLA group (P¼0.31), suggesting that there is
organ specificity for the effect of dietary LA on gastric carcinoma
metastasis. However, as the level of lymph node metastases
was already substantial in the LLA group, it is possible that the
mechanisms responsible for this process are already maximally
activated, potentially masking an effect of LA on lymph node
colonisation.
Fatty acid profiling of blood plasma
To examine the spectrum of fatty acids present in the duodenum
(site of initial absorption), duodenal tissue sections were cut at
necropsy from immunocompromised mice fed the various diets.
Subsequent mass spectral analysis revealed an increase in duo-
denal LA concentrations in mice fed the VHLA diet (43.6±
10.9wt%) compared with mice fed the LLA diet (18.5±2.5wt%)
(Supplementary Table 3; Po0.02).
To determine circulating fatty acid levels, plasma was separated
from whole blood collected at the time of necropsy. As in the
duodenal fatty acid analysis, we observed an increase in plasma LA
concentrations in mice of the VHLA group compared with mice of
the LLA group (Supplementary Table 4). In contrast to duodenal
Table 3 Effect of indomethacin on metastasis of OCUM-2MD3 cells in nude mice
LLA diet VHLA diet
Ethanol Indomethacin Ethanol Indomethacin
Incidence 5/8 (63%)
a 1/7 (14%)
a 8/8 (100%)
a 5/7 (71%)
a
Total nodules 26 4
b 46
b 29
c,d
Nodules per mouse 3.3±2.8
e 0.6±1.5
b,e 5.8±1.8
c,e 4.1±3.2
c,d,e
Total volume per mouse (mm
3) 823.6±922.2
e 25.1±66.5
b,e 6155.9±4562.9
b,e 2194.0±2408.6
c,d,e
Body weight 16.7±0.8
a 17.1±1.0
a 17.3±0.9
a 17.1±1.0
a
Abbreviations: LLA¼low linoleic acid; VHLA¼very high linoleic acid.
aValues are means±s.e.m. (n¼7 or 8).
bSignificantly different from LLA ethanol; Po0.03.
cSignificantly different from VHLA ethanol; Po0.03.
dSignificantly different from LLA indomethacin; Po0.03.
eValues are means±s.d. (n¼7 or 8).
Table 2 Effect of dietary fatty acid on growth of implanted gastric
tumours and incidence of peritoneal metastasis nodules from OCUM-
2MD3 cells in nude mouse
Dietary group
Treatment group LLA VHLA
Gastric tumours
Incidence 9/9 (100%) 9/9 (100%)
Total volume (mm
3) 5019±4971
a 8512±5897
a
Metastasis
Peritoneum 1/9 (11%) 6/9 (67%)
b
Lymph node 4/9 (44%) 6/9 (67%)
Liver invasion 2/9 (100%) 7/9 (78%)
b
Body weight (g) 17.5±0.3
c 16.5±0.7
c
Abbreviations: LLA¼low linoleic acid; VHLA¼very high linoleic acid.
aValues
are means±s.d.
bSignificantly different from LLA group; Po0.03.
cValues are
means±s.e.m.
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stissue, plasma levels of AA were also found to be higher in mice fed
the VHLA diet. These results confirmed that higher amounts of LA
were absorbed in the small intestine, and that higher amounts of
both LA and AA were present in circulating plasma of mice fed the
VHLA diet.
Stimulation of OCUM-2MD3 cell invasion through
Matrigel by LA
On the basis of the fact that the total tumour volumes in the VHLA
group increased over those in either the LLA or HLA groups
in mice, we investigated whether LA influenced the growth or
apoptosis of OCUM-2MD3 cells by growth assay and flow
cytometry. Contrary to prediction, LA treatment had no influence
on the proliferation within 30mM, and showed cytotoxicity at 60mM
(Figure 2A). Percentage of apoptosis in OCUM-2MD3 cells treated
with 30mM LA was also not significantly altered (Figure 2B).
Linoleic acid had no effect on adhesion of OCUM-2MD3 cells, as
measured on Matrigel-coated membrane filters (data not shown).
Therefore, we next investigated the effect of LA on the invasive
capability of OCUM-2MD3 cells. Interestingly, LA strongly
enhanced OCUM-2MD3 cell invasion through Matrigel
(Figure 2C). The increased invasion occurred at both 48 and 72h
of incubation (Figure 2D). Similarly, 30mM AA, a metabolite of LA,
increased the invasion of OCUM-2MD3 cells through Matrigel after
72h (control¼167±17 cells per field vs AA-treated¼334±19
cells per field; n¼3; Po0.01). Linoleic acid also increased invasion
of other scirrhous gastric carcinoma cells, OCUM-12, NUGC3 and
MKN-45, through Matrigel-coated membranes (Figure 2E).
Role of ERK activity in the modulation of
OCUM-2MD3 cell invasion
To examine possible mechanisms for how LA may stimulate
invasion in these tumour cells, we examined whether signalling
pathways involving MAPK (Palmantier et al, 1996, 2001; Paine
et al, 2000) were involved in gastric carcinoma cell invasion
modulated by dietary fatty acids. Serum-starved OCUM-2MD3
cells were exposed to 30mM LA for 5–180min, and whole
cell extracts were prepared. Linoleic acid treatment resulted in
increased level of the phosphorylated form of ERK1/2, which was
evident by 5min and extended to at least 1h (Figure 3A). In
contrast, we observed no consistent phosphorylation of either p38
or SAPK/JNK after treatment with LA in OCUM-2MD3 cells
(Figure 3A). PD98059, a specific inhibitor of ERK activation,
efficiently blocked ERK phosphorylation (Figure 3A) and also
blocked the LA-induced increase in OCUM-2MD3 cell invasion
through Matrigel (Figure 3B). In contrast, the inhibitor did not
block unstimulated cell invasion. SB203580, a specific p38 MAPK
inhibitor, did not alter the LA-stimulated invasion ability
of OCUM-2MD3 cells (Figure 3C). These results suggest that the
ERK signalling pathway, but not p38 or JNK, is involved in
LA-enhanced invasion by these human gastric carcinoma cells in vitro.
A COX inhibitor blocks the invasion ability and metastasis
of gastric carcinoma cells by LA
We next examined the effect of inhibitors of both LOX and COX on
the ability of LA to stimulate invasion of the gastric carcinoma
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scells. Indomethacin, a general inhibitor of COX activity, decreased the
LA-enhanced invasion of OCUM-2MD3 cells (Figure 3D). In contrast,
the LOX inhibitor, NDGA, failed to inhibit invasion of this gastric
carcinoma cell line through Matrigel. These data suggested that COX
activity is required, in part, for LA-enhanced invasion in vitro and
possibly LA-stimulated metastasis in vivo. We then examined the
effects of indomethacin in the mouse model for experimental
metastasis. As before, the incidence and size of visible tumour
nodules in mice injected i.p. with OCUM-2MD3 cells were greater in
the VHLA than in the LLA group (Table 3). Indomethacin had an
inhibitory effect on both the number and volume of metastatic
nodules per mouse in the LLA group. Similarly, the total volume of
metastases per mouse was lower in the VHLA mice treated with
indomethacin, compared with the control (ethanol) group. The
incidence of tumour metastasis and the number of metastatic
colonies were also reduced in the indomethacin-treated, VHLA
group, although the reductions were not as large.
COX-1, but not COX-2, is expressed in OCUM-2MD3 cells
and in metastatic nodules
The ability of indomethacin to block tumour cell metastasis and
growth suggested that a COX was involved. Thus, we examined
OCUM-2MD3 cells for the expression of the two isoforms of COX,
COX-1 and COX-2. The COX-1 protein and mRNA were present in
cultured OCUM-2MD3 cells, as determined by immunoblotting
(Figure 4A) and RT-PCR (data not shown), respectively. We found
no detectable levels of COX-2 protein in cultured cells (Figure 4A).
After injection, metastatic nodules were obtained from both
LLA- and VHLA-fed mice. Metastatic nodules taken from the
two groups of mice expressed approximately equal levels of both
COX-1 protein and COX-1 mRNA (Figure 4B). Immunohisto-
chemistry also revealed COX-1 expression in metastatic nodules
(Figure 4C). In contrast, we did not detect expression of COX-2
protein, either by immunoblotting or by immunohistochemical
analysis (Figure 4B and C).
Inhibition of COX activity prevents activation of ERK
in OCUM-2MD3 cells
To determine whether COX activity is required for LA-induced
phosphorylation of ERK in OCUM-2MD3 cells, the COX inhibitor
indomethacin was used. Phosphorylation of ERK was inhibited by
indomethacin (Figure 4C). These results support the hypothesis
that COX activity is required for ERK activation in response to LA.
(×106) Control  (×102)
Vehicle (ethanol)
LA (30 M)
LA (60 M)
0.09%
% Apoptosis
P
r
o
p
i
d
i
u
m
 
i
o
d
i
d
e
10
8
4
6
2
Annexin V-FITC
01 0 8 6 4 2
(×102)
LA (30 M) (×102)
4
3
2
1 % Apoptosis a
0.00%
10
6
8
2
4
48 24 72
01 0 8 6 4 2
P
r
o
p
i
d
i
u
m
 
i
o
d
i
d
e
Annexin V-FITC
a,b
a
a
a
I
n
v
a
s
i
v
e
 
c
e
l
l
s
 
p
e
r
 
f
i
e
l
d
I
n
v
a
s
i
v
e
 
c
e
l
l
s
 
p
e
r
 
f
i
e
l
d
a
500
400
300
200
100
0
500
400
300
200
100
0
Linoleic acid (M)
10 30 3 0
24 48 72
Time (h)
a
I
n
v
a
s
i
v
e
 
c
e
l
l
s
 
p
e
r
 
f
i
e
l
d Linoleic acid 30 (M)
Ethanol
a a
120
100
80
60
40
20
0
OCUM-12 NUGC3 MKN45
(×102)
Figure 2 The effect of dietary LA on the invasion ability of OCUM-2MD3 cells through Matrigel. (A) Growth of OCUM-2MD3 cell lines after LA
treatment. As described in the Materials and methods section, the number of viable OCUM-2MD3 cells with or without 30mM of LA treatment for the
indicated time period was determined. (B) Apoptosis induction by LA. Upper panel: the typical examples of flowcytometic analysis in OCUM-2MD3 cells
treated with vehicle (ethanol); apoptosis rate was 0.9%. Lower panel: analysis of cells treated with 30mM of LA; apoptosis rate was 0.0%. (C) Cells were
treated for 45min with vehicle (ethanol) or the indicated concentration of LA. Invasion across Matrigel-coated membranes was assessed after 72h.
a: Different from 0mM LA (Po0.01). b: Different from 3 and 10mM LA (Po0.05). (D) Cells were treated with ethanol (dotted line) or 30mM LA (solid line)
and allowed to invade for the indicated time periods. a: Different from the ethanol-treated sample at the same time (Po0.05). (E) OCUM-12, NUGC3 and
MKN-45 cells were treated with ethanol (dotted line) or 30mM LA (solid line). Invasion across Matrigel-coated membranes was assessed after 72h.
a: Different from 0mML A( Po0.01). Values shown are mean±s.d. (n¼4).
Linoleic acid stimulates gastric cancer metastasis
T Matsuoka et al
1187
British Journal of Cancer (2010) 103(8), 1182–1191 & 2010 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
sDISCUSSION
This study shows for the first time that scirrhous gastric carcinoma
cells are impacted in their ability to metastasise in a mouse model
by the dietary administration of (n-6)-PUFA. This is true both
when tumour cells are injected into the i.p. space as well as when
tumours are grafted onto the stomach wall. The levels of LA in the
diets used (in terms of energy from LA) are higher than in most
human diets (Arab, 2003). However, the relative abundance of LA
measured in circulating mouse plasma in the VHLA group of our
study are very similar to those measured in humans on certain
high-fat diets (Skeaff et al, 2006), suggesting that the studies
presented here are relevant to potential consequences in human
disease. In this experimental metastasis study, the incidence of
peritoneal metastasis, as well as the number of tumour nodules
and total tumour volume, increased when LA was included at high
levels in the diet. Although this model excludes the early steps
of metastasis, gastric tumours are known to metastasise to
the peritoneal cavity, and the presence of gastric tumour cells in
the peritoneal cavity is a well-described marker for identifying
patients who are at increased risk of peritoneal recurrence (Burke
et al, 1998; Hayes et al, 1999). To better simulate the full metastatic
cascade, we used an orthotopic graft model in which tumour
sections, derived from tumours grown subcutaneously in a
different mouse, were implanted on the stomach wall. This
procedure led not only to efficient peritoneal metastasis but also
to liver invasion and lymph node metastasis. Although the
incidence of lymph node metastasis was not altered between LLA
and HLA groups, liver invasion and peritoneal metastasis were
higher in VHLA group. This result suggested that fatty acid intake
may influence organ-specific metastasis of these cells, perhaps by
altering the environment within host target sites and facilitating
specific steps in the process of metastasis.
To address this question, we investigated the effect of LA on
invasion, a critical step in the metastatic cascade. Linoleic acid
increased OCUM-2MD3 cell invasion through Matrigel in an
in vitro invasion assay. These results are consistent with reports
indicating increased invasion of breast carcinoma cells treated
with LA (Rose et al, 1994, 1995). Interestingly, LA did not affect the
proliferation, apoptosis or adhesion of OCUM-2MD3 cells to
Matrigel, indicating that increased invasion by LA was not caused
by the enhancement of growth or adhesion of this cell line. To
confirm that the response to LA is common in gastric carcinoma
cells, we next sought to address whether other scirrhous gastric
carcinoma cell lines had the similar response to LA. Interestingly,
three cell lines, OCUM-12, NUGC3 and MKN-45, treated with LA
showed a significant enhancement of invasive ability, indicating
that LA effect might be common in scirrhous-type gastric cancer.
These results contrast with previous reports in other types of
tumour cells. For example, both our group and Johanning and Lin
(1995) previously demonstrated that (n-6)-PUFA promoted adhe-
sion of breast carcinoma cell lines to extracellular matrix. These
differences may be the result of cell-specific signalling pathways.
Nie et al (2000) described that eicosanoids regulated prostate
cancer progression both positively and negatively, depending on
the expression of enzymes such as COX, LOX and P450.
One mechanism by which fatty acids may enhance invasion is
the secretion or activation of metalloproteases (Rose et al, 1994).
0 LA (30 M)
P-ERK
P-p38
P-JNK
0 15 25
0
0
LA (M)
PD (M)
0
25
30
05
30 30
25
300
100
0
200
400
I
n
v
a
s
i
v
e
 
c
e
l
l
s
 
p
e
r
 
f
i
e
l
d
ERK1
0
PD (M)
0 30 30 0 30 03 0
P-ERK
LA (M)
NS
NS
I
n
v
a
s
i
v
e
 
c
e
l
l
s
 
p
e
r
 
f
i
e
l
d
300
400
200
100
0
0 LA (M)
SB (M) 0
0
0
30 30
11 0
a
a
* P < 0.05
b
b
a,b
a,b
NS
NS
I
n
v
a
s
i
o
n
(
p
e
r
c
e
n
t
 
o
f
 
c
o
n
t
r
o
l
)
250
200
150
100
50
0
03 0 3 0 3 0
05
Indomethacin
(M)
NDGA
(M)
25
30 30 30
10 02 0
LA (mol l–1) 30
10
ERK1/2
5 15 30 60 120180 min.
Figure 3 Linoleic acid induces activation of ERK MAPK, which is required for cell invasion. (A) Upper panel: linoleic acid (LA, 30mM) was added to
suspended OCUM-2MD3 cells for the indicated time periods, after which lysates were analysed by SDS-polyacrylamide gel electrophoresis (50mg of protein
per lane). Lower panel: cells were pre-treated with the ERK inhibitor, PD98059 (PD) at the indicated concentration for 60min and treated with either 0 or
30mM LA for 30min and then analysed as above. (B) OCUM-2MD3 cells were pre-treated with the ERK inhibitor, PD98059 (PD), and then with LA at the
indicated concentrations and tested for invasion through Matrigel. a: Different from 0mM LA (Po0.05). b: Different from 30mM LA (Po0.05). (C) Cells were
treated as above except that they were incubated in the presence or absence of the p38 inhibitor, SB203580 (SB), at the indicated concentrations, and
tested for invasion. (D) Cells were treated as above except that they were incubated in the presence or absence of indomethacin or NDGA at the indicated
concentration. a: Different from 0mM LA (Po0.05). b: Different from 30mM LA (Po0.05). Values shown are mean±s.d. (n¼4). NS, not significant.
Linoleic acid stimulates gastric cancer metastasis
T Matsuoka et al
1188
British Journal of Cancer (2010) 103(8), 1182–1191 & 2010 Cancer Research UK
T
r
a
n
s
l
a
t
i
o
n
a
l
T
h
e
r
a
p
e
u
t
i
c
sWe did not detect a change in the production or secretion of
several metalloproteinases in OCUM-2MD3 cells stimulated with
LA based on immunoblotting and gelatin zymography (data not
shown). We also examined the expression of urinary plasminogen
activator (UPA), an important factor known to induce proteolytic
activity. Linoleic acid treatment did not induce UPA expression
in OCUM-2MD3 cells, as measured by immunoblotting (data not
shown).
We did find that the ERK inhibitor, PD98059, clearly reduced
the LA-enhanced invasion of OCUM-2MD3 cells, suggesting that
this signalling pathway has an important role in LA-stimulated
gastric carcinoma cell invasion. Linoleic acid did not consistently
activate p38 or SAPK/JNK, and the increased invasion was
not sensitive to the p38 inhibitor SB203580, suggesting that these
pathways are not necessary for LA-enhanced invasion in these
cells. Other studies have shown that LA activates p38 and
SAPK/JNK in stromal fibroblasts (Westermarck et al, 2000) and
endothelial (Shin et al, 2001) cells. Therefore, it is likely that there
is cell-type specificity with respect to LA activation of p38 and JNK
pathways. Moreover, we found that pre-treatment of OCUM-2MD3
cells with indomethacin inhibited ERK phosphorylation in vitro,
suggesting that the observed ERK activation is downstream
of COX activity.
Our finding that a COX inhibitor, but not a LOX inhibitor,
impaired LA-induced invasion of gastric carcinoma cells led us to
investigate the effect of a COX inhibitor on peritoneal metastasis
in vivo. Administration of indomethacin in drinking water
inhibited the frequency and extent of peritoneal implantation,
thus, serving as a proof of principle experiment for reducing
tumour metastasis with inhibitors of fatty acid metabolism.
These results led us to examine the expression pattern of COX
in OCUM-2MD3 cells. The COX-1, but not COX-2, was present in
both cultured cells and metastatic nodules. Thus, it appears that
COX-1 is primarily responsible for the enhanced metastatic effects
of LA. As reviewed by Tsujii et al (1998), COX-1 expression
regulates angiogenesis in endothelial cells. Therefore, it is
conceivable that the ability of COX-1 to increase metastatic
tumour formation in vivo may be through enhanced angiogenesis.
Moreover, the unaltered expression of COX-1 in the presence of LA
either in OCUM-2D3 cells or metastatic nodules in vivo suggests
that any increase in LA metabolism may primarily be due to
increased activity of COX-1, related to a higher substrate
availability. Although our study has focused on COX expression
in cultured cells and metastatic nodules, a complete understanding
of the metastatic process will require measurement of the whole
spectrum of LA metabolites, as a variety of biological effects,
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sincluding dissemination and metastasis, may be exerted by several
different eicosanoid metabolites (Mathias and Dupont, 1985).
A number of studies have suggested the importance of dietary
fatty acids and their metabolism for human cancer development,
either through animal models (Connolly et al, 1996), epidemiology
of human populations (Armstrong and Doll, 1975) or cell culture
systems (Horia and Watkins, 2007). Examples now exist in
melanoma (Xia et al, 2006), hepatocellular (Rohr-Udilova et al,
2008), breast (Rose, 1997a), prostate (Angelucci et al, 2008) and
pancreatic (Funahashi et al, 2008) cancers in which tumour cells
are effected by (n-6)-PUFA. In some studies, (n-3)-PUFA appear to
antagonise the effects of the (n-6) fatty acids (Funahashi et al,
2008), or have growth or metastasis inhibitory effects by
themselves (Xia et al, 2006). Our work now adds gastric carcinoma
to the list, and, when considered with the other models, suggests
that specific components in the diet may influence a wide variety
of cancers, making dietary modulation an attractive candidate for
altering the aggressiveness of pre-existing cancers.
We (Palmantier et al, 1996; Nony et al, 2005) and others
(Liu et al, 1991) have previously shown that metabolites of LA and
AA can activate signalling pathways that regulate tumour cell
behaviour. Our work with breast carcinoma cells showed that
activation of TAK-1, a transforming growth factor receptor-
associated kinase, is a key component of one of these pathways
(Nony et al, 2005). It is interesting that others have now found the
TGF-b pathway to be important for spreading and invasion of
gastric carcinoma cells (Lee et al, 2005). This raises the question of
whether metabolites of LA are working through the TGF-b
pathway in gastric carcinoma cells.
Our results suggest that dietary LA promotes invasion and
peritoneal metastasis of gastric carcinoma cells through an ERK-
dependent pathway. Indomethacin treatment may contribute to
impaired invasion and COX-1 activity. Results from our studies
may provide information to suggest novel treatment and preven-
tion options, as well as information useful in guiding the
formulation of diets to enhance the protection of humans treated
for cancer.
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